West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 206,900 | 150,700 | 143,600 | 95,600 | 127,100 |
| Depreciation Amortization | 104,400 | 96,700 | 90,700 | 89,900 | 90,000 |
| Income taxes - deferred | 900 | 41,700 | 21,500 | -8,900 | 7,000 |
| Accounts receivable | -43,800 | -39,700 | -23,300 | -14,100 | -6,300 |
| Accounts payable and accrued liabilities | 400 | 12,600 | 6,100 | 17,200 | -3,500 |
| Other Working Capital | -28,300 | -41,400 | -58,700 | -10,800 | -30,600 |
| Other Operating Activity | 48,100 | 42,700 | 39,500 | 43,500 | -800 |
| Operating Cash Flow | $288,600 | $263,300 | $219,400 | $212,400 | $182,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 7,500 |
| PPE Investments | -104,700 | -130,800 | -170,200 | -131,600 | -111,900 |
| Net Acquisitions | N/A | -6,000 | N/A | N/A | N/A |
| Purchase Of Investment | 0 | 0 | -8,400 | -1,500 | -500 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -200 |
| Other Investing Activity | 3,900 | 3,200 | 2,800 | 3,600 | 900 |
| Investing Cash Flow | $-100,800 | $-133,600 | $-175,800 | $-129,500 | $-104,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | N/A | 263,400 |
| Debt Repayment | -100 | -34,900 | -69,800 | 44,000 | -285,700 |
| Common Stock Issued | 32,300 | 40,100 | 29,700 | 15,900 | 17,100 |
| Common Stock Repurchased | -70,800 | -74,400 | -55,900 | -5,600 | -4,100 |
| Dividend Paid | -42,100 | -39,100 | -35,800 | -32,400 | -29,100 |
| Other Financing Activity | 0 | -700 | 17,900 | -63,400 | 7,600 |
| Financing Cash Flow | $-80,700 | $-109,000 | $-113,900 | $-41,500 | $-30,800 |
| Exchange Rate Effect | -5,600 | 12,200 | -1,300 | -22,100 | -22,800 |
| Beginning Cash Position | 235,900 | 203,000 | 274,600 | 255,300 | 230,000 |
| End Cash Position | 337,400 | 235,900 | 203,000 | 274,600 | 255,300 |
| Net Cash Flow | $101,500 | $32,900 | $-71,600 | $19,300 | $25,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 288,600 | 263,300 | 219,400 | 212,400 | 182,900 |
| Capital Expenditure | -104,700 | -130,800 | -170,200 | -131,600 | -111,900 |
| Free Cash Flow | 183,900 | 132,500 | 49,200 | 80,800 | 71,000 |